Discount Agreement for Ranibizumab (OBO)
DAK-Gesundheit is seeking partners for a non-exclusive discount agreement for Ranibizumab. This allows all pharmaceutical companies to join under the same conditions until an exclusive contract takes effect.
CONTRACTING AUTHORITY
Name
DAK-Gesundheit
City
Hamburg
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
46 days remaining(LOT-0001)
Published